Medicine and Dentistry
Neoplasm
100%
Positron Emission Tomography
100%
Bevacizumab
100%
Antiangiogenic
100%
Hsp90 Inhibitor
100%
Luminespib
100%
Vasculotropin
71%
Xenograft
42%
Vascular Tissue Neoplasm
42%
Heat Shock Protein 90
42%
Biological Marker
14%
Ex Vivo
14%
Ovarian Cancer
14%
Cisplatin
14%
Enzyme Linked Immunosorbent Assay
14%
Angiogenesis
14%
Chaperone
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Bevacizumab
100%
Antiangiogenic
100%
Heat Shock Protein 90 Inhibitor
100%
Luminespib
100%
Vasculotropin
71%
Vascular Tumor
42%
Heat Shock Protein 90
42%
Biological Marker
14%
Ovary Cancer
14%
Cisplatin
14%
Chaperone
14%
Enzyme-Linked Immunosorbent Assay
14%
Neuroscience
Positron Emission Tomography
100%
Heat Shock Protein 90
100%
Bevacizumab
100%
Vascular Endothelial Growth Factor
71%
In Vivo
14%
Staining Technique
14%
Angiogenesis
14%
Cisplatin
14%
Chaperone
14%
Transcription Factor
14%
Immunology and Microbiology
Heat Shock
100%
Bevacizumab
100%
Vasculotropin
71%
Xenograft
42%
Enzyme-Linked Immunosorbent Assay
14%
Angiogenesis
14%
Keyphrases
Growth Aspects
14%
Ki67 Staining
14%
Mean Vessel Density
14%
Tumor Response Evaluation
14%